Skip to main content
. Author manuscript; available in PMC: 2014 Aug 16.
Published in final edited form as: Neuroimmunomodulation. 2013 Aug 16;20(6):10.1159/000351716. doi: 10.1159/000351716

Table III.

Minus and plus strand PR8 RNA presence in the OB and lungs 24 hours and 6 days post-viral challenge.

OB Lung
24 hours Minus Plus Minus Plus
(Genomic) (Replicating) (Genomic) (Replicating)
Treatment Group PR8 (NP) RNA PR8 (NP) RNA PR8 (NP) RNA PR8 (NP) RNA
Negative control 0/9 0/9 0/10 0/10
Positive control 8/10 0/10 10/10 10/10
Immunized 7/10 0/10 9/10 6/10
OB Lung
Day 6 Minus Plus Minus Plus
(Genomic) (Replicating) (Genomic) (Replicating)
Treatment Group PR8 (NP) RNA PR8 (NP) RNA PR8 (NP) RNA PR8 (NP) RNA
Negative control 0/5 0/5 0/8 0/8
Positive control 4/5 3/5 10/10 10/10
Immunized 1/5 0/5 3/10 1/10